ATE321547T1 - Halogenierte aminobenzophenonen und aminobenzoylpyridinen als inhibitoren von il-1 und tnf - Google Patents
Halogenierte aminobenzophenonen und aminobenzoylpyridinen als inhibitoren von il-1 und tnfInfo
- Publication number
- ATE321547T1 ATE321547T1 AT02719997T AT02719997T ATE321547T1 AT E321547 T1 ATE321547 T1 AT E321547T1 AT 02719997 T AT02719997 T AT 02719997T AT 02719997 T AT02719997 T AT 02719997T AT E321547 T1 ATE321547 T1 AT E321547T1
- Authority
- AT
- Austria
- Prior art keywords
- aminobenzoylpyridines
- aminobenzophenones
- tnf
- halogenated
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0107368.3A GB0107368D0 (en) | 2001-03-23 | 2001-03-23 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE321547T1 true ATE321547T1 (de) | 2006-04-15 |
Family
ID=9911454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02719997T ATE321547T1 (de) | 2001-03-23 | 2002-03-22 | Halogenierte aminobenzophenonen und aminobenzoylpyridinen als inhibitoren von il-1 und tnf |
Country Status (11)
Country | Link |
---|---|
US (1) | US6919336B2 (de) |
EP (1) | EP1379234B1 (de) |
AR (1) | AR035446A1 (de) |
AT (1) | ATE321547T1 (de) |
DE (1) | DE60210262T2 (de) |
ES (1) | ES2259704T3 (de) |
GB (1) | GB0107368D0 (de) |
MY (1) | MY128242A (de) |
PE (1) | PE20021012A1 (de) |
PT (1) | PT1379234E (de) |
WO (1) | WO2002076447A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002092087A1 (en) | 2001-05-11 | 2002-11-21 | Vertex Pharmaceuticals Incorporated | 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
AU2003223953A1 (en) * | 2002-03-14 | 2003-09-22 | Bayer Healthcare Ag | Monocyclic aroylpyridinones as antiinflammatory agents |
RU2396250C2 (ru) * | 2003-07-24 | 2010-08-10 | Лео Фарма А/С | Новые производные аминобензофенона |
DK1828148T3 (da) * | 2004-12-13 | 2010-05-17 | Leo Pharma As | Triazolsubstituerede aminobenzophenonforbindelser |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
EP2206534A1 (de) | 2008-10-09 | 2010-07-14 | c-a-i-r biosciences GmbH | Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten |
TWI510487B (zh) * | 2010-04-21 | 2015-12-01 | Plexxikon Inc | 用於激酶調節的化合物和方法及其適應症 |
WO2017151409A1 (en) | 2016-02-29 | 2017-09-08 | University Of Florida Research Foundation, Incorporated | Chemotherapeutic methods |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
AU768473B2 (en) * | 1999-07-16 | 2003-12-11 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Novel aminobenzophenones |
EP1237845B1 (de) * | 1999-12-06 | 2007-05-23 | Leo Pharma A/S | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha |
-
2001
- 2001-03-23 GB GBGB0107368.3A patent/GB0107368D0/en not_active Ceased
-
2002
- 2002-03-21 AR ARP020101023A patent/AR035446A1/es unknown
- 2002-03-22 EP EP02719997A patent/EP1379234B1/de not_active Expired - Lifetime
- 2002-03-22 US US10/471,568 patent/US6919336B2/en not_active Expired - Fee Related
- 2002-03-22 PE PE2002000228A patent/PE20021012A1/es not_active Application Discontinuation
- 2002-03-22 AT AT02719997T patent/ATE321547T1/de not_active IP Right Cessation
- 2002-03-22 DE DE60210262T patent/DE60210262T2/de not_active Expired - Fee Related
- 2002-03-22 WO PCT/EP2002/003267 patent/WO2002076447A1/en not_active Application Discontinuation
- 2002-03-22 PT PT02719997T patent/PT1379234E/pt unknown
- 2002-03-22 ES ES02719997T patent/ES2259704T3/es not_active Expired - Lifetime
- 2002-03-23 MY MYPI20021079A patent/MY128242A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2259704T3 (es) | 2006-10-16 |
EP1379234A1 (de) | 2004-01-14 |
PT1379234E (pt) | 2006-07-31 |
EP1379234B1 (de) | 2006-03-29 |
US20040097731A1 (en) | 2004-05-20 |
DE60210262D1 (de) | 2006-05-18 |
PE20021012A1 (es) | 2003-01-03 |
WO2002076447A1 (en) | 2002-10-03 |
US6919336B2 (en) | 2005-07-19 |
DE60210262T2 (de) | 2006-12-28 |
AR035446A1 (es) | 2004-05-26 |
MY128242A (en) | 2007-01-31 |
GB0107368D0 (en) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60020100D1 (de) | Dimerverbindungen und als inhibitoren der neuramidinase | |
DE60221977D1 (de) | Pro-pharmakon von cox-2-inhibitoren | |
DE60103976D1 (de) | Pyrimidinylcarboxamiden als inhibitoren der pde4 isoenzyme | |
DE60221886D1 (de) | 3-cyanochinoline als inhibitoren von egf-r- und her2-kinasen | |
DE60227300D1 (de) | Strukturen von anschlusselementen und anzuschliessende komponente | |
NO20041272L (no) | Tetracycline derivatives and methods of use thereof | |
ATE410421T1 (de) | P38 inhibitor und anwendungsverfahren dafür | |
DE60238206D1 (de) | Frequenz- und amplitudenapodisierung von wandlern | |
NO20033387L (no) | Modifiserte antistoffer og fremgangsmåter for anvendelse | |
NO20041160L (no) | Bio-avlesningsplattform for pavisning og kvantitering av biologiske molekyler | |
DE60021423D1 (de) | 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren | |
DE60212600D1 (de) | Audiocodierung und decodierung | |
BRPI0208558A2 (pt) | preparado de combinação de estrogênio-gestagênio e uso | |
DE60317799D1 (de) | Antimikrobielle zusammensetzung und anwendungsverfahren | |
DE60208159D1 (de) | Antagonisten von mcp-1 tätigkeit und deren verwendungsmethoden | |
ATE357432T1 (de) | Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren | |
NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
DE02784674T1 (de) | Quantifizierung von polypeptiden | |
DE60225014D1 (de) | Pharmazeutische zusammensetzungen von amlodipin und atorvastatin | |
NO20041345L (no) | Kopolymerer for undertrykkelse av autoimmune sykdommer og fremgangsmate for anvendelse | |
IS2867B (is) | Neublastín sem tengt er fjölliðu og aðferðir við notkun þess | |
ATE499096T1 (de) | Kombination von serotonin-wiederaufnahme-hemmern und agomelatin | |
ATE321547T1 (de) | Halogenierte aminobenzophenonen und aminobenzoylpyridinen als inhibitoren von il-1 und tnf | |
DE60302152D1 (de) | Diaminothiazole und ihre anwendung als cdk4 inhibitoren | |
NO20033506D0 (no) | Parasittdrepende preparater og fremgangsmåter for anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1379234 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |